News About: Pharm. Industry
Average Product Lifecycles Analyzed Between Two Major Pharmaceutical Markets
The pharmaceutical industry analysis conducted by a research institute in Japan shows a product lifecycle comparison between the top ten revenue-generating products by the major local firms in the Japan market, and th...
Pfizer Korea Announces Financial Results for Year 2004
Pfizer Korea recently announced of its Year 2004 company financial results, generating a total sales revenue of 257.7 billion won which is up 5.4% from the prior fiscal period.
The company's operating profit is 43....
New Chairman of KPMA Stresses on R&D Investments and Activities
The newly appointed Chairman Huh Il-sup of the Korea Pharmaceutical Manufacturers Association (KPMA) expressed in the interview held last week that, under his new leadership, KPMA will continue to focus on promoting a...
KFDA Delays Decision on Hanmi’s Anti-Obesity Drug with Novel Salt Formulation
The delayed decision by the Korea Food and Drug Administration (KFDA) on an approval of Hanmi Pharmaceutical’s anti-obesity drug Slimer is triggering debates on the current regulatory process that governs the approval...
CKD Bio Obtains European CoS Accreditation for Antibiotic Raw Material
CKD Bio Corp., an affiliate of Chong Kun Dang Group specialized in the manufacture of pharmaceutical raw materials, announced that the company has successfully obtained a CoS (Certificate of Suitability) accreditation...
Lilly Korea Plans to Launch Zyprexa IntraMuscular
Lilly Korea recently announced that it plans to introduce Zyprexa IntraMuscular (olanzapine for injection) in the domestic market during the first half of this year, giving the healthcare professionals a new option fo...
7 Pharmaceutical Firms Identified with Extended Dividend Payout Records
Seven domestic pharmaceutical firms are ranked among 39 KSE (Korea Stock Exchange) listed companies that made a consecutive dividend payout for 24 years and more, according to a report released by the Korea Listed Com...
Janssen Korea Introduces New Once-Daily Reminyl PR
Janssen Korea announced early this week an availability of new, long-acting form of Reminyl PR (active ingredient: galantamine hydrobromide) for the treatment of mild to moderate Alzheimer's disease (AD) in the domest...
Daewoong's Urusa Records Over 36 Billion Won of Sales
Daewoong Pharmaceutical recently announced that its popular over-the-counter (OTC) medication Urusa (active ingredient: ursodeoxycholic acid) surpassed over 36 billion won of sales revenue last year, making it as the ...
Boryung Explains Reason for OTC Price Increases
In response to an industry report that Boryung Pharmaceutical is increasing prices for certain over-the-counter (OTC) products with established market recognitions, the company explained that the decision is not refle...
